Charleroi

Belgium

205 total trials 94 recruiting

Filter these 205 trials by phase, condition, sponsor and more.

Open in Search →

A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon … Ended

2023-506981-30-00 4 2022-05-25 Chronic kidney disease in type 2 diabetes mellitus
Tucatinib and trastuzumab in solid tumors with HER2 alterations Ended

2024-511481-37-00 4 2021-07-12 Previously Treated, Locally-Advanced Unresectable or Metastatic Solid
A Study of BMS-986012 in Combination with Carboplatin, Etoposide, andNivolumab as First-line Therapy in Extensive-stage Small Cell Lung Canc … Ended

2024-510700-36-00 4 2021-06-01 Extensive-stage Small Cell Lung Cancer
MK-7684A (new drug co-formulation of pembrolizumab with an anti-TIGIT) plus docetaxel works to help stop or slow down the growth of your non … Ended

2022-501252-28-00 4 2021-04-15 Non Small Cell Lung cancer
Dose Escalation of DF1001 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications Ended

2023-503291-24-00 9 2021-03-17 Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cel … Ended

2022-502480-38-00 5 2020-09-09 Non−small cell lung cancer (NSCLC)
First-line chemotherapy plus pembrolizumab and olaparib for BRCA nonmutated advanced EOC Ended

2022-502124-52-00 5 2018-12-18 Advanced epithelial ovarian cancer
RCT part: COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. LTE part: Long Term observational fol … Ended

2023-510189-28-00 6 2018-05-15 Rheumatoid Arthritis
FFCD 1605- OPTIPRIME: A phase II study evaluating FOLFOX + panitumumab according to a ‘stop-and-go’ strategy with a reintroduction loop afte … Ended

2024-518740-20-00 4 2018-04-26 metastatic colorectal adenocarcinoma
Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: PREDICTUMAB, an open- … Ended

2024-516783-29-00 6 2018-04-16 Severe allergic and eosinophilic asthma
A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC af … Ended

2023-509137-39-00 5 2015-11-06 Stage IB (T ≥ 4 cm), II and IIIA NSCLC
A Phase II Study of MEDI4736 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Ended

2024-512379-10-00 4 2014-09-23 Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIBI
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan … Ended

2023-506487-13-00 5 Hormone receptor-positive, her2-negative advanced/metastatic breast ca

Showing 193–205 of 205 trials